Variables | Clinical (n = 100) | Subclinical (n = 29) | All (n = 129) | p-Value |
---|---|---|---|---|
Age (years) | 48.45 ± 14.14 | 55.84 ± 12.07 | 50.08 ± 14.00 | 0.019 |
Male, % | 25 (25.0%) | 3 (10.3%) | 28 (21.7%) | 0.092 |
BMI, kg/m2 | 25.11 ± 4.07 | 25.58 ± 3.12 | 25.20 ± 3.88 | 0.61 |
Sodium, mmol/L | 143.77 ± 3.57 | 142.58 ± 2.35 | 143.50 ± 3.36 | 0.096 |
Potassium, mmol/L | 3.59 ± 0.72 | 3.95 ± 0.51 | 3.67 ± 0.69 | 0.012 |
Cortisol 0800 (nmol/L) | 668.17 ± 335.29 | 399.06 ± 135.10 | 606.72 ± 321.65 | < 0.001 |
Cortisol 1600 (nmol/L) | 594.13 ± 314.92 | 309.80 ± 173.36 | 527.63 ± 311.83 | < 0.001 |
Cortisol 2400 (nmol/L) | 510.55 ± 269.71 | 218.80 ± 107.88 | 442.32 ± 271.32 | < 0.001 |
Cortisol after LDDST (nmol/L) | 509.25 ± 276.75 | 252.16 ± 157.07 | 447.36 ± 275.57 | < 0.001 |
T3 (nmol/L) | 1.20 ± 0.31 | 1.55 ± 0.73 | 1.27 ± 0.46 | < 0.001 |
T4 (nmol/L) | 79.10 ± 22.80 | 87.53 ± 20.94 | 80.90 ± 22.59 | 0.121 |
FT3 (pmol/L) | 3.27 ± 0.88 | 3.93 ± 0.78 | 3.42 ± 0.90 | < 0.001 |
FT4 (pmol/L) | 13.95 ± 3.37 | 15.57 ± 3.25 | 14.32 ± 3.40 | 0.024 |
TSH (µIU/mL) | 1.15 ± 0.99 | 2.25 ± 1.76 | 1.40 ± 1.29 | < 0.001 |
Thyroid status | 0.005 | |||
Euthyroid | 42 (42.0%) | 19 (65.5%) | 61 (47.3%) | |
Pituitary hypothyroidism | 33 (33.0%) | 1 (3.4%) | 34 (26.4%) | |
Low-T3 | 22 (22.0%) | 6 (20.7%) | 28 (21.7%) | |
Subclinical hypothyroidism | 3 (3.0%) | 3 (10.3%) | 6 (4.7%) | |
ACTH-dependent | 39 (39.0%) | 1 (3.4%) | 40 (31.0%) | < 0.001 |
Location | < 0.001 | |||
Adrenal | 61 (61.0%) | 28 (96.6%) | 89 (69.0%) | |
Adenoma | 57 (93.4%) | 28 (100.0%) | 85 (95.5%) | |
Carcinoma | 4 (6.6%) | 0 (0.0%) | 4 (4.5%) | |
Size, cm | 2.93 ± 1.97 | 2.71 ± 0.87 | 2.86 ± 1.70 | |
Surgery | 53 (86.9%) | 21 (75.0%) | 74 (83.1%) | |
Pituitary | 32 (32.0%) | 0 (0.0%) | 32 (24.8%) | |
Size, mm | 0.42 ± 0.40 | 0 | ||
Surgery | 18 (56.2%) | 0 | ||
Ectopic | 7 (7.0%) | 1 (3.4%) | 8 (6.2%) |